Corbus Pharmaceuticals Holdings (CRBP) Payables (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Payables of $2.2 million for Q4 2025, down 53.72% year-over-year from $4.8 million in Q4 2024, and down 19.16% quarter-over-quarter from $2.7 million in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Payables (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Payables history runs 13 years deep, the most recent figure standing at $2.2 million for Q4 2025.
- In Q4 2025, Payables fell 53.72% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 53.72% YoY), while the FY2025 annual figure was $2.2 million, down 53.72% from the prior year.
- Payables for Q4 2025 stood at $2.2 million, down from $2.7 million in the prior quarter.
- The five-year high for Payables was $4.8 million in Q4 2024, with the low at $1.2 million in Q2 2024.
- The 5-year median for Payables is $2.6 million (2021), against an average of $2.8 million.
- The sharpest annual moves came in 2021 and 2025: Payables slumped 80.66% in 2021, then soared 224.49% in 2025.
- Corbus Pharmaceuticals Holdings' Payables stood at $2.6 million in 2021, then decreased by 0.9% to $2.5 million in 2022, then soared by 37.7% to $3.5 million in 2023, then surged by 37.53% to $4.8 million in 2024, then slumped by 53.72% to $2.2 million in 2025.
- Business Quant data shows CRBP's Payables at $2.2 million in Q4 2025, $2.7 million in Q3 2025, and $4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 3.99 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 2.53 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 3.14 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | 2.67 Mn |
| Jun 30, 2021 | 2.48 Mn |
| Mar 31, 2021 | 4.42 Mn |